Literature DB >> 12524418

A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours.

M Miyaki1, T Iijima, M Ohue, Y Kita, T Hishima, T Kuroki, T Iwama, T Mori.   

Abstract

During a search for causative genes in patients with concurrent multiple primary colon tumours, we found a novel case with a germline mutation of the p53 gene, from GCC (Ala) to GTC (Val) at codon 189. Of the six primary colon tumours that this patient had, one large advanced carcinoma exhibited a somatic p53 mutation and a somatic APC mutation, in addition to the germline p53 mutation. Two early carcinomas and three adenomas had somatic APC mutations but no somatic p53 mutation or loss of the p53 allele. K-ras-2 mutations were detected in an advanced carcinoma and an early carcinoma. The present results suggest that a patient with a certain type of germline p53 mutation is predisposed to concurrent multiple colon tumours. It is also suggested that in such a patient, a somatic APC mutation is involved in tumour formation and that an additional somatic p53 mutation contributes to tumour progression.

Entities:  

Mesh:

Year:  2003        PMID: 12524418      PMCID: PMC1774964          DOI: 10.1136/gut.52.2.304

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.

Authors:  J M Varley; M Thorncroft; G McGown; J Appleby; A M Kelsey; K J Tricker; D G Evans; J M Birch
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

2.  Molecular basis for heterogeneity of the human p53 protein.

Authors:  N Harris; E Brill; O Shohat; M Prokocimer; D Wolf; N Arai; V Rotter
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

3.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource.

Authors:  H T Lynch; W Kimberling; W A Albano; J F Lynch; K Biscone; G S Schuelke; A A Sandberg; M Lipkin; E E Deschner; Y B Mikol
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

6.  A cancer family syndrome in twenty-four kindreds.

Authors:  F P Li; J F Fraumeni; J J Mulvihill; W A Blattner; M G Dreyfus; M A Tucker; R W Miller
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

7.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

8.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.

Authors:  R J Slebos; I O Baas; M Clement; M Polak; J W Mulder; F M van den Berg; S R Hamilton; G J Offerhaus
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more
  5 in total

1.  Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Authors:  Michael A Resnick; Alberto Inga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome.

Authors:  Tsukasa Yoshida; Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Yutaka Hirayama; Nobumasa Mizuno; Kazuo Hara; Susumu Hijioka; Hiroshi Imaoka; Nobuhiro Hieda; Nozomi Okuno; Takashi Kinoshita; Vikram Bhatia; Yasuhiro Shimizu; Yasushi Yatabe; Kenji Yamao; Yasumasa Niwa
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

3.  Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Authors:  Michinori Funato; Yukiko Tsunematsu; Fumito Yamazaki; Chieko Tamura; Tadashi Kumamoto; Masatoshi Takagi; Shunsuke Kato; Haruhiko Sugimura; Kazuo Tamura
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

4.  Germline TP53 c.566C>T mutation incidentally diagnosed during treatment for acute myeloid leukemia: A case report.

Authors:  Hiroshi Sato; Seiki Matsuo; Yukiko Ando; Yuko Imamura; Masaya Hirose
Journal:  Clin Case Rep       Date:  2021-12-16

5.  A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.

Authors:  Yonggeun Cho; Juwon Kim; Yoonjung Kim; Joon Jeong; Kyung-A Lee
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.